Aura Biosciences, Inc.

NASDAQ:AURA

10.88 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 30.07526.27941.08255.58447.73238.492121.58261.1153.849108.382149.06381.82992.19799.69317.393
Short Term Investments 157.341176.595185.08793.472114.281135.0367.22950.40968.28224.89900000
Cash and Short Term Investments 187.416202.874226.169149.056162.013173.522188.811111.519122.131133.281149.06381.82992.19799.69317.393
Net Receivables 000000000000000
Inventory 000000000000000
Other Current Assets 8.189.3755.6250.5660.9885.5790.7120.3060.2610.1310.0660.0550.0311.0280.016
Total Current Assets 195.596212.249231.794153.888166.211179.121196.702115.908127.669139.582153.70483.45892.875100.72118.455
Non-Current Assets:
Property, Plant & Equipment, Net 21.47521.55522.00424.42525.0625.50726.04226.4716.4596.7156.2015.5385.3184.3063.574
Goodwill 000000000000000
Intangible Assets 000000000000000
Goodwill and Intangible Assets 000000000000000
Long Term Investments 0.7680.7680.7680.7680.7680.7680.7680.7680.8930.1250.1250.1250.1250.0750
Tax Assets 000000000000000
Other Non-Current Assets 0.4430.4530.5090.6850.70.6230.42300001.5830.33500.075
Total Non-Current Assets 22.68622.77623.28125.87826.52826.89827.23327.2397.3526.846.3267.2465.7784.3813.649
Total Assets 218.282235.025255.075179.766192.739206.019223.935143.147135.021146.422160.0390.70498.653105.10222.104
Liabilities & Equity:
Current Liabilities:
Account Payables 1.4591.9331.7871.490.5531.0552.9211.7241.1981.9562.4011.7362.4171.3110.611
Short Term Debt 2.7542.7412.6873.0353.0082.9852.9632.9420.6330.6240.6150.6070.6010.3680.015
Tax Payables 000000000000000
Deferred Revenue 0005.3494.5680003.48103.8332.7531.94501.773
Other Current Liabilities 6.3354.9897.8831.020.7664.0674.5735.2980.52.4230.4230.7350.3531.7420.262
Total Current Liabilities 10.5489.66312.35710.8948.8958.10710.4579.9645.8125.0037.2725.8315.3163.4212.661
Non-Current Liabilities:
Long Term Debt 16.2816.57916.8717.15417.40717.65417.89518.1290.0510.2060.360.5130.6610.4940
Deferred Revenue Non-Current 000000000000000
Deferred Tax Liabilities Non-Current 000000000000000
Other Non-Current Liabilities 000000000.0670.1270.08316.649215.4270.068128.156
Total Non-Current Liabilities 16.2816.57916.8717.15417.40717.65417.89518.1290.1180.3330.44317.162216.0880.562128.156
Total Liabilities 26.82826.24229.22728.04826.30225.76128.35228.0935.935.3367.71522.993221.4043.983130.817
Equity:
Preferred Stock 00000000000198.726215.304215.309128.076
Common Stock 000000000000000
Retained Earnings -327.351-307.014-287.308-265.177-246.665-228.366-210.9-194.341-178.44-164.972-152.137-140.503-131.665-122.813-116.886
Accumulated Other Comprehensive Income/Loss -0.1830.0180.539-0.134-0.223-0.045-0.072-0.147-0.128-0.00500000
Other Total Stockholders Equity 518.988515.779512.617417.029413.325408.669406.555309.542307.659306.063304.4529.488-206.398.623-119.903
Total Shareholders Equity 191.454208.783225.848151.718166.437180.258195.583115.054129.091141.086152.31567.711-122.751101.119-108.713
Total Equity 191.454208.783225.848151.718166.437180.258195.583115.054129.091141.086152.31567.711-122.751101.119-108.713
Total Liabilities & Shareholders Equity 218.282235.025255.075179.766192.739206.019223.935143.147135.021146.422160.0390.70498.653105.10222.104